ConductScience.org, home

Paper39025905

A robust cis-Mendelian randomization method with application to drug target discovery.

Lin Z and 1 other. Nat Commun, 2024. Cited by 47 papers, by iCite.

Cite this record

ConductScience Library. A robust cis-Mendelian randomization method with application to drug target discovery. Papers, record 39025905. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39025905

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A robust cis-Mendelian randomization method with application to drug target discovery.
PubMed
Journal
Nat Commun
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
5.5, provisional
iCite
Revised in PubMed
2026-07-17
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lin ZZhaotonghttps://orcid.org/0000-0001-8723-4392
2Pan WWeihttps://orcid.org/0000-0002-1159-0582

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mendelian Randomization AnalysisMajor topic
Polymorphism, Single NucleotideMajor topic
Linkage DisequilibriumMajor topic
Drug DiscoveryMajor topic
Humans
Coronary Artery Disease
Proprotein Convertase 9
Genetic Pleiotropy
Genome-Wide Association Study
Quantitative Trait Loci
Likelihood Functions

Source PubMed

Download CSV of topics

Grants8

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
U01 AG073079NIA NIH HHSUnited StatesU01AG073079PubMed and NIHNIH RePORTER
R01 AG074858NIA NIH HHSUnited StatesR01AG074858PubMed and NIHNIH RePORTER
R01 AG065636, R01 AG069895, RF1 AG067924, U01 AG073079, R01 AG074858, R01 HL116720 and R01 GM126002U.S. Department of Health & Human Services | National Institutes of Health (NIH)R01AG065636PubMed and NIHNIH RePORTER
R01 GM126002NIGMS NIH HHSUnited StatesR01GM126002PubMed and NIHNIH RePORTER
R01 AG069895NIA NIH HHSUnited StatesR01AG069895PubMed and NIHNIH RePORTER
R01 HL116720NHLBI NIH HHSUnited StatesR01HL116720PubMed and NIHNIH RePORTER
RF1 AG067924NIA NIH HHSUnited StatesRF1AG067924PubMed and NIHNIH RePORTER
R01 AG065636NIA NIH HHSUnited StatesR01AG065636PubMed and NIHNIH RePORTER

Download CSV of grants

References57

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127061298Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator.Genet Epidemiol2016https://conductscience.org/library/papers/27061298PubMed
228527048Interpreting findings from Mendelian randomization using the MR-Egger method.Eur J Epidemiol2017https://conductscience.org/library/papers/28527048PubMed
335192729A two-sample robust Bayesian Mendelian Randomization method accounting for linkage disequilibrium and idiosyncratic pleiotropy with applications to the COVID-19 outcomes.Genet Epidemiol2022https://conductscience.org/library/papers/35192729PubMed
429040600Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption.Int J Epidemiol2017https://conductscience.org/library/papers/29040600PubMed
524830394Bayesian test for colocalisation between pairs of genetic association studies using summary statistics.PLoS Genet2014https://conductscience.org/library/papers/24830394PubMed
633004804Mendelian randomization while jointly modeling cis genetics identifies causal relationships between gene expression and lipids.Nat Commun2020https://conductscience.org/library/papers/33004804PubMed
725773378Efficacy and safety of alirocumab in reducing lipids and cardiovascular events.N Engl J Med2015https://conductscience.org/library/papers/25773378PubMed
831028273Mendelian randomization analysis using mixture models for robust and efficient estimation of causal effects.Nat Commun2019https://conductscience.org/library/papers/31028273PubMed
935507585A practical problem with Egger regression in Mendelian randomization.PLoS Genet2022https://conductscience.org/library/papers/35507585PubMed
1028195242The alternative complement pathway is dysregulated in patients with chronic heart failure.Sci Rep2017https://conductscience.org/library/papers/28195242PubMed
1136273411Statistical methods for cis-Mendelian randomization with two-sample summary-level data.Genet Epidemiol2023https://conductscience.org/library/papers/36273411PubMed
1224114802Mendelian randomization analysis with multiple genetic variants using summarized data.Genet Epidemiol2013https://conductscience.org/library/papers/24114802PubMed
1335615025Statistical methods for Mendelian randomization in genome-wide association studies: A review.Comput Struct Biotechnol J2022https://conductscience.org/library/papers/35615025PubMed
1427959767Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes.N Engl J Med2016https://conductscience.org/library/papers/27959767PubMed
1535235357Likelihood-based Mendelian randomization analysis with automated instrument selection and horizontal pleiotropic modeling.Sci Adv2022https://conductscience.org/library/papers/35235357PubMed
1634214446Constrained maximum likelihood-based Mendelian randomization robust to both correlated and uncorrelated pleiotropic effects.Am J Hum Genet2021https://conductscience.org/library/papers/34214446PubMed
1736388766Proteome-wide Mendelian randomization in global biobank meta-analysis reveals multi-ancestry drug targets for common diseases.Cell Genom2022https://conductscience.org/library/papers/36388766PubMed
1832591531Genetic drug target validation using Mendelian randomisation.Nat Commun2020https://conductscience.org/library/papers/32591531PubMed
1937808547Causal Inference in Transcriptome-Wide Association Studies with Invalid Instruments and GWAS Summary Data.J Am Stat Assoc2023https://conductscience.org/library/papers/37808547PubMed
2036948188Robust multivariable Mendelian randomization based on constrained maximum likelihood.Am J Hum Genet2023https://conductscience.org/library/papers/36948188PubMed

See all 57 referencesDownload CSV of references

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
42977791From blood-expression signals to Kawasaki disease biomarkers: promise and limits of KLHL42 and SOS2.Pediatr Res2026https://conductscience.org/library/papers/42977791PubMed
42964882Adiponectin and Pulmonary Hypertension Risk: Mendelian Randomization and Receptor-Side Genetic Evidence.Pulm Circ2026https://conductscience.org/library/papers/42964882PubMed
42877317Brain single-cell transcriptome-informed Mendelian randomization identifies potential druggable therapeutic targets for Alzheimer's disease.J Alzheimers Dis Rep2026https://conductscience.org/library/papers/42877317PubMed
42842067GLP-1R expression and dermatological diseases: a mendelian randomization and real-world study.Endocrine2026https://conductscience.org/library/papers/42842067PubMed
42793049Pharmacology-Informed Human Genetic Evaluation of Panax notoginseng Saponin-Related Candidate Genes for Functional Outcome After Ischemic Stroke Using Mendelian Randomization and Colocalization.Genes (Basel)2026https://conductscience.org/library/papers/42793049PubMed
42784210From Proteomic Signatures to Candidate Endotypes in Obesity, Type 2 Diabetes, MASLD/MASH, and MetALD: Study Designs, Bioinformatics, and Biostatistical Strategies.Proteomes2026https://conductscience.org/library/papers/42784210PubMed
42704269TL-HDMR: a transfer learning framework for advancing equitable causal inference reveals metabolic signatures of stroke across multiple ancestries.Brief Bioinform2026https://conductscience.org/library/papers/42704269PubMed
42704268A flexible framework for robust and efficient Mendelian randomization with debiasing.Brief Bioinform2026https://conductscience.org/library/papers/42704268PubMed
42694095Shared Treg dysregulation underlies psoriasis vulgaris and atopic dermatitis through the PHF19-PRC2 epigenetic axis.Front Immunol2026https://conductscience.org/library/papers/42694095PubMed
42682829Proteome-wide Mendelian randomisation of lung function to identify potential therapeutic targets for respiratory disease.ERJ Open Res2026https://conductscience.org/library/papers/42682829PubMed
42502347Seipin as a Putative Protective Factor for Breast Cancer: Evidence from Mendelian Randomization Analysis.Int J Womens Health2026https://conductscience.org/library/papers/42502347PubMed
42465877Recalibrating Mendelian randomization under winner's curse, sample structure and polygenicity.medRxiv2026https://conductscience.org/library/papers/42465877PubMed
42332333Integration of transcriptome and mendelian randomization elucidates the protective role of aspirin in pulmonary tuberculosis development.Funct Integr Genomics2026https://conductscience.org/library/papers/42332333PubMed
42189912MR2G: A novel framework for causal network inference using GWAS summary data.PLoS Genet2026https://conductscience.org/library/papers/42189912PubMed
42177594Single-cell multi-omic integration analysis prioritizes druggable genes and reveals cell-type-specific causal effects in glioblastomagenesis.J Transl Med2026https://conductscience.org/library/papers/42177594PubMed
42175412Unveiling novel drug targets for atherosclerosis: A Mendelian randomization analysis.Medicine (Baltimore)2026https://conductscience.org/library/papers/42175412PubMed
42009889Repurposing drugs for the prevention of vascular dementia using evidence from drug target Mendelian randomization.Nat Aging2026https://conductscience.org/library/papers/42009889PubMed
41997142A flexible and unified framework for single- and multi-outcome Mendelian randomization using summary statistics.Am J Hum Genet2026https://conductscience.org/library/papers/41997142PubMed
41966688Integrating genetic data with biological insight: A practical guide to cis-Mendelian randomization.Am J Hum Genet2026https://conductscience.org/library/papers/41966688PubMed
41965819Epigenome-wide Mendelian randomization with multi-omics validation identifies epigenetic drivers of idiopathic pulmonary fibrosis.Commun Biol2026https://conductscience.org/library/papers/41965819PubMed

See all 43 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
COLEC1178989PubTator's text mininghttps://conductscience.org/library/genes/78989NCBI Gene
FGFR12260PubTator's text mininghttps://conductscience.org/library/genes/2260NCBI Gene
PCSK9255738PubTator's text mininghttps://conductscience.org/library/genes/255738NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39025905

GET https://conductscience.org/api/papers/v1/39025905/references?page=2